Details
Stereochemistry | ACHIRAL |
Molecular Formula | C9H5Cl2NO |
Molecular Weight | 214.048 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=C2N=CC=CC2=C(Cl)C=C1Cl
InChI
InChIKey=WDFKMLRRRCGAKS-UHFFFAOYSA-N
InChI=1S/C9H5Cl2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H
Molecular Formula | C9H5Cl2NO |
Molecular Weight | 214.048 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Chloroxine, a dichloroquinolinol, was first prepared by A. Hebebrand in 1888. It is an antibacterial drug that has been incorporated into shampoos to treat dandruff and seborrheic dermatitis. It has also been used internally as an antidiarrheal and in the lab as an analytical reagent. The drug was withdrawn from the market in the US by unknown reason.
Approval Year
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
0.713 μg/g EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/16910862/ |
2 μL single, oral dose: 2 μL route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROXINE plasma | Oryctolagus cuniculus population: HEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
60.72 μg × min/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/16910862/ |
2 μL single, oral dose: 2 μL route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROXINE plasma | Oryctolagus cuniculus population: HEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
48.72 min EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/16910862/ |
2 μL single, oral dose: 2 μL route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROXINE plasma | Oryctolagus cuniculus population: HEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
PubMed
Title | Date | PubMed |
---|---|---|
Genotoxicity of ochratoxin A and structurally related compounds in Escherichia coli strains: studies on their mode of action. | 1991 |
|
Structure-activity studies in E. coli strains on ochratoxin A (OTA) and its analogues implicate a genotoxic free radical and a cytotoxic thiol derivative as reactive metabolites. | 1994 May 1 |
|
Solid phase extractive preconcentration of thorium onto 5,7-dichloroquinoline-8-ol modified benzophenone. | 2002 Oct 16 |
|
A monooxygenase catalyzes sequential dechlorinations of 2,4,6-trichlorophenol by oxidative and hydrolytic reactions. | 2004 Feb 20 |
|
Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells. | 2005 |
|
Solid phase extraction preconcentration of cobalt and nickel with 5,7-dichloroquinone-8-ol embedded styrene-ethylene glycol dimethacrylate polymer particles and determination by flame atomic absorption spectrometry (FAAS). | 2005 Apr 15 |
|
Selective recognition of neodymium (III) using ion imprinted polymer particles. | 2005 Jan-Feb |
|
Prediction of genotoxicity of chemical compounds by statistical learning methods. | 2005 Jun |
|
Ion imprinted polymer particles for separation of yttrium from selected lanthanides. | 2006 Jun |
|
The evaluation of liposome-water partitioning of 8-hydroxyquinolines and their copper complexes. | 2006 Mar 15 |
|
Investigation of the role of chelating ligand in the synthesis of ion-imprinted polymeric resins on the selective enrichment of uranium(VI). | 2007 Mar 28 |
|
Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands. | 2007 Nov 1 |
|
Synthesis of nano-pore samarium (III)-imprinted polymer for preconcentrative separation of samarium ions from other lanthanide ions via solid phase extraction. | 2008 Aug 8 |
|
5,7-Dichloro-quinolin-8-ol. | 2009 Apr 25 |
|
N,N-Dicyclo-hexyl-2-(5,7-dichloro-8-quinol-yloxy)acetamide. | 2009 Oct 7 |
|
Fragment-based discovery of 8-hydroxyquinoline inhibitors of the HIV-1 integrase-lens epithelium-derived growth factor/p75 (IN-LEDGF/p75) interaction. | 2013 Mar 28 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.drugs.com/pro/capitrol.html
Curator's Comment: Chloroxine is used as a topical shampoo containing 2% (w/w) chloroxine.
Apply onto the wet scalp, leave on for approximately three minutes, then rinse.
Route of Administration:
Topical
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:13:57 GMT 2023
by
admin
on
Fri Dec 15 15:13:57 GMT 2023
|
Record UNII |
2I8BD50I8B
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29708
Created by
admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
212-258-3
Created by
admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
|
PRIMARY | |||
|
C004357
Created by
admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
|
PRIMARY | |||
|
CHEMBL1200596
Created by
admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
|
PRIMARY | |||
|
2722
Created by
admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
|
PRIMARY | |||
|
2I8BD50I8B
Created by
admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
|
PRIMARY | |||
|
3904
Created by
admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
|
PRIMARY | |||
|
Chloroxine
Created by
admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
|
PRIMARY | |||
|
59477
Created by
admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
|
PRIMARY | |||
|
SUB13339MIG
Created by
admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
|
PRIMARY | |||
|
DB01243
Created by
admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
|
PRIMARY | |||
|
100000091041
Created by
admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
|
PRIMARY | |||
|
611
Created by
admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
|
PRIMARY | |||
|
773-76-2
Created by
admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
|
PRIMARY | |||
|
C47446
Created by
admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
|
PRIMARY | |||
|
DTXSID5022801
Created by
admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
|
PRIMARY | |||
|
20875
Created by
admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
|
PRIMARY | RxNorm | ||
|
m3451
Created by
admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |